Chris Henshall was Senior Director of Strategic Marketing at West Pharmaceutical Services. In this role, he was responsible for the development and delivery of strategic and operational commercialisation plans across the biologics portfolio. Mr Henshall has >20 years’ pharma and biotech industry experience. He has led and launched multiple brands in his career both domestically and globally.
Innovations in self-administered drug delivery systems are transitioning care out of hospitals and clinical settings into the home. To ensure patient compliance with treatment is maintained, an easy-to-use self-administration system can be key. Chris Henshall discusses the factors manufacturers should consider to ensure self-injected therapies meet patients’ needs and therefore improve patient outcomes.